Google
IP Stock Price & Analysis — Inter Pharma Public Company Limited (Healthcare >> Biotechnology)
IP FAQ
What is IP's P/E ratio?
Inter Pharma Public Company Limited (IP) currently trades at a P/E ratio of 24.57.
What is IP's ROE?
Inter Pharma Public Company Limited reports a Return on Equity (ROE) of 6.35%.
What is IP's dividend yield?
Inter Pharma Public Company Limited offers a dividend yield of 1.38%.
What is IP's Quality Score?
Our AI rates IP's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy IP?
Our AI Timing Score for IP is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does IP belong to?
Inter Pharma Public Company Limited is classified under the Healthcare >> Biotechnology sector on the MAI exchange
IP AI Analysis Summary
Our AI summary for IP: Inter Pharma Public Company Limited (MAI), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 24.57, ROE of 6.35%, a dividend yield of 1.38%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
THB 5.40
Price
0.10
(1.89%)
Day Change
|
|
|---|
IP, the overall quality is ok ( Quality = 69) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROE is relatively low.
Historical ROE is relatively low
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.04 From 30 days period |
| Watch Rate | 0.13 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
511
|
| Magic Formula Rank by ROE |
511
|
| Magic Formula Rank by ROIC |
519
|
| Price | 5.40 |
| PBV / Sector |
1.40 / 1.40
GOOD
|
| Earning Per Share | 0.22 |
| PE / Sector |
24.57 / 24.57
|
| PEG or PE/Growth / Sector |
0.66 / 0.66
|
| Average 1M Daily Value |
2.78 M
GREAT
|
| Average 1W Daily Value |
2.28 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
62% |
| Return to Investors |
|
12% |
| Registration Details |
| Analyze Date | 2026-08-04 05:27:17 |
| Symbol | IP |
| Name | INTER PHARMA PUBLIC COMPANY LIMITED |
| Sector | Healthcare >> Biotechnology |
| Market | MAI |
| Listed Shares | 605.34 M |
| Par Value | 1.00 |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.Baht) / Sector Average | 3,268.86 / 3,268.86 |
| News, Concensus, ... |
| Estimation Consensus | See at SetTrade.com |
| Full details | See at SET.or.th |
| Chart | See in Chart feature |
| News | See at RYT9.com |
Address: No. 140/9 ITF Tower, Bangkok, Thailand, 10500
Phone: 66 2 634 0225
Website: https://www.interpharma.co.th
Sector: Healthcare >> Biotechnology
Description: Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equipment and medicines, etc. It also provides pet healthcare and livestock products, such as medical supplies, nutrition therapy, vaccine, supplementary food, probiotic and prebiotic products, animal health food products, animal food, general formula animal food, nutraceuticals and medicine companion products, ear and teeth cleaners, pee pads, shampoos, and medical equipment related to pet and livestock care product, etc. In addition, the company provides care and treatment for patients with general and specialized diseases, such as cardiovascular disease, bone and joint disease, neuropathy, medical diseases, surgical diseases, kidney disease, obstetrics and gynecology, ear, eye, nose, throat diseases, blood diseases, pediatric clinics, etc. It serves retail customers through distributors. The company was incorporated in 2006 and is headquartered in Bangkok, Thailand.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
